Crossmark

Rituximab as frontline monotherapy in untreated hairy cell leukemia patients

Crossref DOI link: https://doi.org/10.1007/s00277-015-2328-9

Published Online: 2015-02-13

Published Print: 2015-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Akinosoglou, K.

Melachrinou, M.

Makatsoris, T.

Sakellakis, M.

Papakonstantinou, C.

Gogos, C. A.

Solomou, E. E.
License Information

Text and Data Mining valid from 2015-02-13